Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women

Metabolism: Clinical and Experimental

Volumn 57, Issue 4, 2008, Pages 473-478

  Gray, Dona L ^a   O'Brien, Kevin D ^b   D'Alessio, David A ^c   Brehm, Bonnie J ^d   Deeg, Mark A ^a,e  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; PHOSPHOLIPASE D;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW CARBOHYDRATE DIET; LOW FAT DIET; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; FEMALE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; PHOSPHOLIPASE D; WEIGHT LOSS;

EID: 39849102064     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.11.007     Document Type: Article

References (38)

1. Deeg M.A., Bierman E.L., and Cheung M.C. GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. J Lipid Res 42 (2001) 442-451
2. Hoener M.C., and Brodbeck U. Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins. Eur J Biochem 206 (1992) 747-757
3. Xie M., Sesko A.M., and Low M.G. Glycosylphosphatidylinositol-specific phospholipase D is localized in keratinocytes. Am J Physiol 265 (1993) C1156-C1168
4. Deeg M.A., and Verchere C.B. Regulation of GPI-specific phospholipase D secretion from βTC3 cells. Endocrinology 138 (1997) 819-826
5. Xie M., and Low M.G. Expression and secretion of glycosylphosphatidylinositol-specific phospholipase D by myeloid cell lines. Biochem J 297 (1994) 547-554
6. Stadelmann B., Zurbiggen A., and Brodbeck U. Distribution of glycosylphosphatidylinositol-specific phospholipase D mRNA in bovine tissue sections. Cell Tissue Res 274 (1993) 547-552
7. LeBoeuf R.C., Caldwell M., Guo Y., Metz C., Davitz M.A., Olson L.K., et al. Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization. Mamm Genome 9 (1998) 710-714
8. Kurtz T.A., Fineberg N.S., Considine R.V., and Deeg M.A. Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D. Metab Clin Exp 53 (2004) 138-139
9. Raikwar N.S., Cho W.K., Bowen R.F., and Deeg M.A. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab 290 (2006) E463-E470
10. Chalasani N., Vuppalanchi R., Raikwar N.S., and Deeg M.A. Glycosylphosphatidylinositol-specific phospholipase D in nonalcoholic fatty liver disease: a preliminary study. J Clin Endocrinol Metab 91 (2006) 2279-2285
11. Brehm B.J., Seeley R.J., Daniels S.R., and D'Alessio D.A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 88 (2003) 1617-1623
12. O'Brien K.D., Brehm B.J., Seeley R.J., Bean J., Wener M.H., Daniels S., et al. Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 90 (2005) 2244-2249
13. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
14. Deeg M.A., Raikwar N.S., Johnson C., and Williams C.D. Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D. Transl Res 150 (2007) 153-157
15. Deeg M.A., Bowen R.F., Williams M.D., Olson L.K., Kirk E.A., and LeBoeuf R.C. Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes. Am J Physiol Endocrinol Metab 281 (2001) E147-E154
16. Bowen R.F., Raikwar N.S., Olson L.K., and Deeg M.A. Glucose and insulin regulate GPI-specific phospholipase D expression in islet b cells. Metab Clin Exp 50 (2001) 1489-1492
17. Seshadri P., Iqbal N., Stern L., Williams M., Chicano K.L., Daily D.A., et al. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med 117 (2004) 398-405
18. Malle E., and De Beer F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26 (1996) 427-435
19. Tannock L.R., O'Brien K.D., Knopp R.H., Retzlaff B., Fish B., Wener M.H., et al. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 111 (2005) 3058-3062
20. Leinonen E., Hurt-Camejo E., Wiklund O., Hulten L.M., Hiukka A., and Taskinen M.R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166 (2003) 387-394
21. Johnson B.D., Kip K.E., Marroquin O.C., Ridker P.M., Kelsey S.F., Shaw L.J., et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 726-732
22. Ebeling P., Teppo A.M., Koistinen H.A., Viikari J., Ronnemaa T., Nissen M., et al. Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with type II diabetes. Diabetologia 42 (1999) 1433-1438
23. Meek R.L., Urieli-Shoval S., and Benditt E.P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A 91 (1994) 3186-3190
24. O'Brien K.D., Pineda C., Chiu W.S., Bowen R., and Deeg M.A. Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes. Circulation 99 (1999) 2876-2882
25. Volek J.S., and Sharman M.J. Cardiovascular and hormonal aspects of very-low-carbohydrate ketogenic diets. Obesity research 12 Suppl 2 (2004) 115S-123S
26. Thamer C., Haap M., Bachmann O., Zur Nieden T., Tschritter O., Stefan N., et al. Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia 47 (2004) 1303-1305
27. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med 37 (2005) 347-356
28. Tamura Y., Tanaka Y., Sato F., Choi J.B., Watada H., Niwa M., et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 90 (2005) 3191-3196
29. Greco A.V., Mingrone G., Giancaterini A., Manco M., Morroni M., Cinti S., et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51 (2002) 144-151
30. Westerbacka J., Lammi K., Hakkinen A.M., Rissanen A., Salminen I., Aro A., et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90 (2005) 2804-2809
31. Mostad I.L., Qvigstad E., Bjerve K.S., and Grill V.E. Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes. Scand J Clin Lab Invest 64 (2004) 565-574
32. Kasim-Karakas S.E., Tsodikov A., Singh U., and Jialal I. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 83 (2006) 774-779
33. Vessby B., Unsitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44 (2001) 312-319
34. Lichtman S.W., Pisarska K., Berman E.R., Pestone M., Dowling H., Offenbacher E., et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 327 (1992) 1893-1898
35. Bandini L.G., Schoeller D.A., Cyr H.N., and Dietz W.H. Validity of reported energy intake in obese and nonobese adolescents. Am J Clin Nutr 52 (1990) 421-425
36. Prentice A.M., Black A.E., Coward W.A., Davies H.L., Goldberg G.R., Murgatroyd P.R., et al. High levels of energy expenditure in obese women. Br Med J (Clin Res Ed) 292 (1986) 983-987
37. O'Brien K.D., Alpers C.E., Hokanson J.E., Wang S., and Chait A. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein. Circulation 94 (1994) 1216-1225
38. Subramanian S., O'Brien K.D., Kirk E., and Chait A. Dietary cholesterol selectively increases visceral adipose tissue macrophage accumulation in obese LDL receptor-deficient mice. Program of the ATVB 2007 Annual Conference (2007), American Heart Association, Dallas, TX 105